Arcus Biosciences, INC. (RCUS) SEC Filings — 2024
21 SEC filings for Arcus Biosciences, INC. (RCUS) in 2024.
Filings
- Rosen Amends Arcus Biosciences Stake Filing — SC 13D/A · Dec 17, 2024
- Arcus Biosciences, INC. SC 13G/A Filing — SC 13G/A · Nov 12, 2024
- Arcus Biosciences, INC. SC 13G/A Filing — SC 13G/A · Nov 8, 2024
- Arcus Biosciences Q3 2024 10-Q Filed — 10-Q · Nov 6, 2024
- Gilead to Acquire Arcus Biosciences for $12.8B — 8-K · Oct 24, 2024
- Arcus Biosciences, INC. SC 13G/A Filing — SC 13G/A · Oct 23, 2024
- Arcus Biosciences, INC. SC 13G/A Filing — SC 13G/A · Oct 17, 2024
- Arcus Biosciences Enters New Credit Agreement — 8-K · Aug 27, 2024
- Arcus Biosciences Q2 Revenue Surges on Licensing Deals — 10-Q · Aug 8, 2024
- Arcus Biosciences Files 8-K — 8-K · Jun 6, 2024
- Gilead to Acquire Arcus Biosciences for $12.8B — 8-K · Jun 3, 2024
- Gilead to Acquire Arcus Biosciences for $12.8 Billion — 8-K · May 23, 2024
- Arcus Biosciences, Inc. Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 8, 2024
- Arcus Biosciences, Inc. Files Definitive Proxy Statement — DEF 14A · Apr 23, 2024
- Arcus Biosciences, Inc. Files 2023 Annual Report on Form 10-K — 10-K · Feb 21, 2024
- Arcus Biosciences, INC. SC 13G/A Filing — SC 13G/A · Feb 13, 2024
- FMR LLC Discloses 6.317% Passive Stake in Arcus Biosciences — SC 13G · Feb 9, 2024
- Gilead Amends Arcus Biosciences Stake, Signals Ownership Change — SC 13D/A · Jan 31, 2024
- Arcus Biosciences Reports Material Agreement, Equity Sales, Officer Comp Changes — 8-K · Jan 30, 2024
- State Street Corp. Discloses Passive Stake in Arcus Biosciences — SC 13G · Jan 24, 2024
- BlackRock Trims Arcus Biosciences Stake to 9.0% — SC 13G/A · Jan 23, 2024